Skip to main content
Clinical Trials/ACTRN12618001661268
ACTRN12618001661268
Completed
Phase 3

Effects of Moringa oleifera leaf powder supplementation in pregnant mothers on maternal health and birth weight in Jeneponto District, South Sulawesi Indonesia.

Prof. Veni Hadju0 sites20 target enrollmentStarted: October 9, 2018Last updated:

Overview

Phase
Phase 3
Status
Completed
Sponsor
Prof. Veni Hadju
Enrollment
20

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
17 Years to 41 Years (—)
Sex
Female

Inclusion Criteria

  • Hemoglobin between 10 to 11gr/dl
  • \-Age of pregnancy is equal or above 28 weeks
  • \-Parity is equal or less than three
  • \-Willing to participate into the study

Exclusion Criteria

  • Mothers who consumed other supplements.
  • Mothers with pregnancy complications such as hypertension, diabetes, others)
  • Mothers with bleeding.

Investigators

Sponsor
Prof. Veni Hadju

Similar Trials